当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS杂志
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
基本信息
期刊名称 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
CANCER BIOTHER RADIO
期刊ISSN 1084-9785
期刊官方网站 http://www.liebertpub.com/overview/cancer-biotherapy-and-radiopharmaceuticals/8/
是否OA
出版商 Mary Ann Liebert Inc.
出版周期 Bimonthly
始发年份 1996
年文章数 57
最新影响因子 3.4(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验4区
ONCOLOGY 肿瘤学4区
PHARMACOLOGY & PHARMACY 药学4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 1.70 0.545 0.609
Medicine
Radiology Nuclear Medicine and imaging
110 / 272 59%
Biochemistry, Genetics and Molecular Biology
Cancer Research
151 / 191 21%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
173 / 300 42%
Medicine
Oncology
205 / 321 36%
补充信息
自引率 4.00%
H-index 51
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1084-9785%5BISSN%5D
投稿指南
期刊投稿网址 http://mc.manuscriptcentral.com/Cancerbiotherapy
收稿范围

Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments. 

Cancer Biotherapy and Radiopharmaceuticals coverage includes:

  • Antibody drug conjugates
  • Fusion toxins and immunotoxins
  • Nanoparticle therapy
  • Vascular therapy
  • Inhibitors of proliferation signaling pathways

Cancer Biotherapy and Radiopharmaceuticals is under the editorial leadership of Editor-in-Chief Martin W. Brechbiel, PhD and other leading investigators.

Audience: Oncologists, nuclear medicine researchers, radiologists, cancer researchers, pathologists, and epidemiologists, among others.


收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Editor-in-Chief

Martin W. Brechbiel, PhD
Bethesda, MD

Associate Editors

Robert O. Dillman, MD
University of California, Irvine
Aivita Biomedical, Inc. 
18301 Von Karmann Avenue
Irvine, CA 92612
bob@avitabiomedical.com

M. R. A. Pillai, PhD, DSc
Molecular Group of Companies
Kerala, India
pillai.mra@molecularglobal.com
pillai.m.r.a@gmail.com

Associate Editor for Asia

Zhi Yang, PhD
Beijing Cancer Hospital & Institute
Peking University
Beijing, China
pekyz@163.com

Managing Editor 

Karen Cloud-Hansen, PhD
kcloudhansen@liebertpub.com

Editorial Board

Gregory P. Adams, PhD
Elucida Oncology, Inc.
Monmouth Junction, NJ

Carolyn J. Anderson, PhD
University of Pittsburgh
Pittsburgh, PA

Christina M. Annunziata, MD, PhD
Women’s Malignancy Branch, NCI
Bethesda, MD

Philip M. Arlen, MD
Precision Biologics, Inc.
Rockville, MD

Joseph J. Barchi Jr., PhD
National Cancer Institute
Frederick, MD

Richard P. Baum, MD
THERANOSTICS Research Center, Zentralklinik Bad Berka
Bad Berka, Germany

Benjamin Bonavida, MD
University of California, Los Angeles
Los Angeles, CA

Eszter Boros, MSc, PhD
Stony Brook University 
Stony Brook, NY

Sunju Choi, PhD
Korea Atomic Energy Research Institute 
Daejeon, South Korea

Cathy S. Cutler, PhD
Brookhaven National Laboratory
Upton, NY 

Ekaterina Dadachova, PhD
University of Saskatchewan
Saskatoon, SK, Canada

Jean-Francois Gestin, PhD
CRCINA - INSERM 
Nantes, France

Rodney Hicks, MD
The Peter MacCallum Cancer Centre
Melbourne, Australia

Seigo Kinuya, MD
Kanazawa University Graduate School
of Medicine
Kanazawa, Japan

Shweta Kotian, PhD
U. S. Food and Drug Administration
Silver Spring, MD 

Suzanne Lapi, PhD
University of Alabama at Birmingham
Birmingham, AL

Jason S. Lewis, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

Francesco M. Marincola, MD
Sidra Medical and Research Center
Doha, Qatar

James D. Marks, MD
San Francisco General Hospital
San Francisco, CA

Ruby Meredith, MD, PhD
University of Alabama at Birmingham
Birmingham, AL

Yubin Miao, PhD
University of Colorado Denver
Aurora, CO

Thomas P. Quinn, PhD
University of Missouri
Columbia, MO

Raymond M. Reilly, PhD
University of Toronto
Toronto, ON, Canada

Domenico Rubello, MD
Santa Maria Della Misericordia Hospital
Rovigo, Italy
 

Orazio Schillaci, MD, PhD
University of Rome
Rome, Italy

Andrew M. Scott, MD
Olivia Newton-John Cancer Research Institute
Heidelberg, VC, Australia

George Sgouros, PhD
Johns Hopkins University
Baltimore, MD

DeeDee K. Smart, MD, PhD
National Cancer Institute
Bethesda, MD

Michael Stabin, PhD
Vanderbilt University
Nashville, TN

Daniel Thorek, PhD
Washington University School of Medicine
St Louis, MO

Kwong Y. Tsang, PhD
Precision Biologics, Inc.
Rockville, MD

J. Harvey Turner, MD
Fremantle Hospital/Western Australia
University 
Fremantle, WA, Australia

Guus A.M.S van Dongen, PhD
VU University Medical Center
Amsterdam, Netherlands

Meera Venkatesh, PhD
 
International Atomic Energy Agency
Vienna, Austria
 

Anna M. Wu, PhD
David Geffen School of Medicine at UCLA 
Los Angeles, CA

Jim Xiang, MD, PhD
University of Saskatchewan 
Saskatchewan, SK, Canada

Hiroki Yamaue, MD
Wakayama Medical University Hospital
Wakayama, Japan

John R. Yannelli, PhD
University of Kentucky
Lexington, KY


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug